Plain-English translation of NCT06733766 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This multicenter study evaluates ultrasound-guided thermal ablation—a procedure that uses heat to destroy cancer cells—for patients whose thyroid cancer has come back after surgery. Researchers want to understand how well and how safely this treatment works over the long term, and whether it can help patients avoid more invasive procedures.
When thyroid cancer returns after surgery, patients often have limited treatment options. This trial exists to determine whether this minimally invasive heat-based treatment could offer patients a safer, gentler alternative to traditional surgery or other therapies.
You likely qualify if…
You likely don't qualify if…
You would receive the ultrasound-guided heat treatment, which is performed as an outpatient procedure guided by imaging. After treatment, you would return for regular follow-up visits and imaging scans over at least 12 months so doctors can monitor how well the treatment worked and watch for any side effects.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China
Enrollment target
~300 participants
Started
December 2024
Primary completion
December 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lin Yan
Chinese PLA General Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.